It is essential to have detailed information about compounds identified in screening campaigns during drug discovery and to know their influence on cell cycle progression or DNA repair. The discovery of Chromobodies® and advancements in High Content Imaging systems with improved optical properties and live cell capabilities has opened the door for new reliable and robust screening assays that provide these relevant high quality data.